Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 5 studies | 26% ± 7% | |
epithelial cell | 4 studies | 30% ± 4% | |
natural killer cell | 4 studies | 22% ± 5% | |
CD4-positive, alpha-beta T cell | 4 studies | 27% ± 12% | |
CD8-positive, alpha-beta T cell | 4 studies | 25% ± 9% | |
conventional dendritic cell | 3 studies | 21% ± 7% | |
B cell | 3 studies | 23% ± 5% | |
erythroblast | 3 studies | 33% ± 14% | |
regulatory T cell | 3 studies | 22% ± 8% |
Insufficient scRNA-seq data for expression of POLR3K at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 536.25 | 2641 / 2642 | 100% | 26.93 | 705 / 705 |
intestine | 100% | 393.41 | 966 / 966 | 100% | 42.64 | 526 / 527 |
ovary | 100% | 319.16 | 180 / 180 | 100% | 23.22 | 429 / 430 |
thymus | 100% | 386.37 | 653 / 653 | 100% | 30.03 | 603 / 605 |
stomach | 100% | 338.39 | 359 / 359 | 100% | 33.44 | 285 / 286 |
prostate | 100% | 416.72 | 245 / 245 | 100% | 33.77 | 500 / 502 |
skin | 100% | 365.54 | 1805 / 1809 | 100% | 44.06 | 471 / 472 |
breast | 100% | 371.98 | 459 / 459 | 99% | 54.58 | 1112 / 1118 |
bladder | 100% | 409.29 | 21 / 21 | 99% | 37.53 | 501 / 504 |
uterus | 99% | 334.85 | 169 / 170 | 100% | 39.28 | 458 / 459 |
kidney | 100% | 366.97 | 89 / 89 | 99% | 17.40 | 891 / 901 |
adrenal gland | 100% | 512.44 | 258 / 258 | 99% | 28.03 | 227 / 230 |
lung | 99% | 340.42 | 570 / 578 | 100% | 33.30 | 1154 / 1155 |
esophagus | 100% | 366.56 | 1443 / 1445 | 98% | 17.85 | 180 / 183 |
pancreas | 98% | 193.30 | 322 / 328 | 99% | 23.68 | 177 / 178 |
liver | 100% | 259.01 | 226 / 226 | 97% | 16.64 | 392 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 25.10 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 78.85 | 29 / 29 |
spleen | 100% | 631.23 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.35 | 1 / 1 |
adipose | 100% | 319.16 | 1201 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 337.90 | 800 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 309.98 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 300.60 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 570.91 | 860 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045087 | Biological process | innate immune response |
GO_0051607 | Biological process | defense response to virus |
GO_0006386 | Biological process | termination of RNA polymerase III transcription |
GO_0006383 | Biological process | transcription by RNA polymerase III |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005666 | Cellular component | RNA polymerase III complex |
GO_0001056 | Molecular function | RNA polymerase III activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0003899 | Molecular function | DNA-directed 5'-3' RNA polymerase activity |
Gene name | POLR3K |
Protein name | Alternative protein POLR3K DNA-directed RNA polymerase III subunit RPC10 (RNA polymerase III subunit C10) (DNA-directed RNA polymerase III subunit K) (RNA polymerase III 12.5 kDa subunit) (RPC12.5) (RNA polymerase III subunit C11) (HsC11p) (RPC11) (hRPC11) |
Synonyms | RPC11 My010 |
Description | FUNCTION: Core component of RNA polymerase III (Pol III) which synthesizes small non-coding RNAs using the four ribonucleoside triphosphates as substrates . Can mediate Pol I proofreading of the nascent RNA transcript. Anchors into the Pol III active site to constantly monitor transcription fidelity, cleaves mis-incorporated 5'-ribonucleotides and restarts the transcription process. Once Pol III reaches the poly(dT) termination signal, can induce Pol III clamp opening and transcription termination (By similarity). Pol III plays an important role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as a nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF-kappa-B through the RIG-I pathway . . |
Accessions | L0R6M6 Q9Y2Y1 ENST00000293860.6 |